Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 15/20 | 0.60 |
| ▸ | HCRTR2 | O43614 | 15/20 | 0.60 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.42 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1398732 | 1.00 | HCRTR1 (0.60) | HCRTR1HCRTR2CHRM2CHRM4CHRM5 | |
| SCHEMBL1398696 | 1.00 | HCRTR1 (0.60) | HCRTR1HCRTR2CHRM2CHRM4CHRM5 | |
| SCHEMBL1398535 | 0.92 | HCRTR1 (0.51) | HCRTR1HCRTR2MAPK1 | |
| SCHEMBL4787256 | 0.87 | HCRTR1 (0.52) | HCRTR1HCRTR2 | |
| SCHEMBL1398688 | 0.84 | HCRTR1 (0.44) | HCRTR1HCRTR2CHRM2CHRM4CHRM5 | |
| SCHEMBL1398667 | 0.84 | HCRTR1 (0.44) | HCRTR1HCRTR2CHRM2CHRM4CHRM5 | |
| SCHEMBL1398846 | 0.84 | HCRTR1 (0.44) | HCRTR1HCRTR2CHRM2CHRM4CHRM5 | |
| SCHEMBL1398694 | 0.84 | HCRTR1 (0.72) | HCRTR1HCRTR2 | |
| SCHEMBL1398655 | 0.84 | HCRTR1 (0.72) | HCRTR1HCRTR2 | |
| SCHEMBL1398645 | 0.84 | HCRTR1 (0.72) | HCRTR1HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7994336-B2 | Azetidine compounds as orexin receptor antagonists | ACTELION PHARMACEUTICALS LTD. (CH) | 2011-08-09 | — | — | US | disclosed |
| EP-2069332-B1 | AZETIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2011-03-02 | — | — | EP | disclosed |